What Has Been the Growth of the Coagulation Markers Market So Far?
The coagulation markers market has seen considerable growth due to a variety of factors.
• The coagulation markers market has grown significantly in recent years. It is projected to increase from $1.16 billion in 2024 to $1.25 billion in 2025, with a CAGR of 7.1%.
This growth is driven by the rising incidence of cardiovascular diseases, an aging population, more surgical procedures, better awareness and early diagnosis, government support, and expanding healthcare infrastructure.
What Are the Future Growth Projections for the Coagulation Markers Market?
The coagulation markers market is expected to maintain its strong growth trajectory in upcoming years.
• The coagulation markers market is projected to grow strongly, reaching $1.63 billion by 2029, at a CAGR of 6.9%.
This growth is attributed to the rising incidence of chronic diseases, personalized medicine adoption, growing population, healthcare expenditures, and emerging markets. Major trends include AI/ML integration, novel biomarkers, point-of-care technologies, automation, wearable health tech, and telehealth.
What Are The Core Factors Supporting Growth In The Coagulation Markers Market?
The rising prevalence of blood disorders is expected to spur growth in the coagulation markers market. Blood disorders affect the blood's ability to function properly, and the prevalence is increasing due to factors like aging populations and improved diagnosis. Coagulation markers are used to diagnose and manage blood disorders by assessing clotting functions and monitoring treatment effectiveness. The Leukaemia Foundation reported that around 135,000 people in Australia live with blood cancer or a blood disorder, and this number is expected to exceed 275,000 by 2035. The increasing prevalence of blood disorders is driving the coagulation marker market.
What Are The Major Segments Within The Global Coagulation Markers Market?
The coagulation markers market covered in this report is segmented –
1) By Product: D-Dimer Assay, Fibrinogen Assay
2) By Sample Type: Plasma, Whole Blood Sample, Other Sample Types
3) By Technology: Fluorescence Immunoassay, Enzyme-Linked Immuno Sorbent Assay (ELISA), Rapid Test, Particle Enhanced Immunoturbidimetric Assay
4) By Application: Deep Venous Thrombosis (DVT), Pulmonary Embolism (PE), Disseminated Intravascular Coagulation (DIC), Trauma, Other Applications
5) By End User: Hospital, Specialty Clinics, Academic And Research Institute, Diagnostics Laboratories
Subsegments:
1) By D-Dimer Assay: ELISA-Based D-Dimer Assay, Lateral Flow Immunoassay D-Dimer Test, Chemiluminescent Immunoassay D-Dimer Test
2) By Fibrinogen Assay: Clauss Fibrinogen Assay, Functional Fibrinogen Assay, Automated Fibrinogen Assay
Pre-Book The Coagulation Markers Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
What Trends Are Shaping The Coagulation Markers Market?
Companies in the coagulation markers market are developing tools like D-dimer kits to improve the diagnosis of blood clot conditions. In July 2024, Bionote Inc., a US-based biotech company, introduced the Vcheck D-dimer 5Tests/Kit, an immunodiagnostic tool designed for veterinary use to detect blood clot formation and breakdown, helping diagnose conditions like thrombosis and sepsis in animals.
Who Are the Key Players In The Coagulation Markers Market?
Major companies operating in the coagulation markers market are:
• Siemens Healthineers
• Roche Holding AG
• Thermo Fisher Scientific Inc.
• Abbott Laboratories
• Quidel Corporation
• Sysmex Corporation
• Bio-Rad Laboratories Inc.
• Werfen Group
• Nihon Kohden Corporation
• Randox Laboratories Ltd
• Stago Group
• Sekisui Diagnostics
• Helena Laboratories Italia Spa
• Tulip Diagnostics Ltd
• Trinity Biotech PLC
• CTK Biotech Inc.
• International Technidyne Corporation (ITC)
• Diazyme Laboratories Inc.
• AdvaCare Pharma USA (AccuQuik Test Kits)
• Technoclone GmbH
• BioMedica Diagnostics Inc.
• Eurolyser Diagnostica GmbH
• Goldsite Diagnostics Inc.
• Hipro Biotechnology Co. Ltd.
• HYPHEN BioMed
What Is The Most Dominant Region In The Coagulation Markers Market?
North America was the largest region in the coagulation markers market in 2024. The regions covered in the coagulation markers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
